Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT was delisted on the 2nd of December, 2024.
52 hedge funds and large institutions have $3.26M invested in Oncternal Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 7 closing their positions.
4% less funds holding
Funds holding: 54 → 52 (-2)
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
58% less capital invested
Capital invested by funds: $7.86M → $3.26M (-$4.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RB
Richmond Brothers
Jackson,
Michigan
|
+$83.3K |
| 2 |
Millennium Management
New York
|
+$49.2K |
| 3 |
Renaissance Technologies
New York
|
+$10.5K |
| 4 |
Morgan Stanley
New York
|
+$10.4K |
| 5 |
BWP
Balboa Wealth Partners
Scottsdale,
Arizona
|
+$9.89K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
BIT Capital
Berlin,
Germany
|
-$566K |
| 2 |
BlackRock
New York
|
-$41.4K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$35.4K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$19K |
| 5 |
CWA
CM Wealth Advisors
Beachwood,
Ohio
|
-$16K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
JP Morgan Chase
New York
| $9 | – | – | – |
|
|
DAM
52
Delta Asset Management
Memphis,
Tennessee
| $2 | – | – | – |
|
|
BC
53
BIT Capital
Berlin,
Germany
| – | -$566K | -36,673 | Closed |
|
|
CWA
54
CM Wealth Advisors
Beachwood,
Ohio
| – | -$16K | -2,782 | Closed |
|
|
HCM
55
Hollencrest Capital Management
Newport Beach,
California
| – | -$8.64K | -550 | Closed |
|
56
Simplex Trading
Chicago,
Illinois
| – | -$5K | -356 | Closed |
|
57
Citadel Advisors
Miami,
Florida
| – | -$1.29K | -196 | Closed |
|
58
Fidelity Investments
Boston,
Massachusetts
| – | -$970 | -62 | Closed |
|
|
GGI
59
Godsey & Gibb Inc
Richmond,
Virginia
| – | -$15 | -1 | Closed |
|
60
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$422 | +64 | New |
|
ONCT Hedge Fund Activity: Q2 2023 in Review
52 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Oncternal Therapeutics, Inc. Common Stock (ONCT) for Q2 2023, worth a combined $3.26M — down 58% from $7.86M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ONCT and 5 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 9 added.
The largest buyer was Richmond Brothers, adding an estimated $83.3K. The largest seller was BIT Capital, exiting entirely with an estimated $566K sold.
- 52 institutional investors held Oncternal Therapeutics, Inc. Common Stock (ONCT) as of Q2 2023, down from 54 in Q1 2023.
- Funds reported $3.26M of Oncternal Therapeutics, Inc. Common Stock stock for Q2 2023, down 58% quarter-over-quarter.
- 5 funds opened new Oncternal Therapeutics, Inc. Common Stock positions in Q2 2023 and 7 closed out, a net change of -2 holders.
- The largest Oncternal Therapeutics, Inc. Common Stock buyer in Q2 2023 was Richmond Brothers, an estimated $83.3K added.
- The largest Oncternal Therapeutics, Inc. Common Stock seller in Q2 2023 was BIT Capital, an estimated $566K sold.
Based on aggregated 13F filings for Q2 2023.